Navigation Links
Tracon Pharmaceuticals to Present Clinical Stage Programs at AACR 2009
Date:2/17/2009

SAN DIEGO, Feb. 17 /PRNewswire/ -- Tracon Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and related diseases, announced today that its three clinical stage cancer therapeutics (TRC105, TRC102, and TRC093) will be presented at the 100th Annual Meeting of the American Association for Cancer Research this April 18-22 in Denver, Colorado. "Each program targets a unique pathway with the potential for broad application to a wide variety of cancer types, and we are pleased that all three will be presented at this year's meeting" explained Bryan Leigh, MD, Chief Medical Officer at Tracon Pharmaceuticals.

TRC105 is a chimeric IgG1 monoclonal antibody that binds CD105, a membrane receptor required for angiogenesis. By inhibiting new blood vessel formation, the antibody is expected to have activity against a wide variety of solid tumors that rely on angiogenesis to grow and metastasize. Clinical data from a phase 1 first-in-human study of TRC105 therapy for advanced cancer was recently presented at the 11th International Symposium on Anti-Angiogenic Agents in San Diego, CA by Michael S. Gordon, MD (Premiere Oncology, Scottsdale, AZ). TRC105 may also be a useful therapy for age-related macular degeneration, the most common cause of blindness in people over the age of 50.

TRC102 is a small molecule inhibitor of base excision repair that improves the therapeutic index of commonly used antimetabolite and alkylating agent chemotherapies. The molecule is currently being studied as an oral agent in combination with pemetrexed (Alimta(R)) and as an i.v. agent in combination with temozolomide (Temodar(R)).

TRC093 is a humanized IgG1 monoclonal antibody that inhibits angiogenesis, tumor growth, and metastasis by binding cleaved collagen in the extracellular matrix of cancers. This antibody is expected to address multiple solid tumor types and may also be developed for age-relate
'/>"/>

SOURCE Tracon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. The Effects of Probiotics on the Aging Digestive Tract to be Presented at Nutracon 2009
2. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
3. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
4. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
5. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results
6. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
7. Portola Pharmaceuticals Enters Worldwide License Agreement for Development and Commercialization of Novel Antiplatelet Drug Elinogrel
8. Valeant Pharmaceuticals to Announce 2008 Fourth Quarter and Year Results on February 24, 2009
9. Biotest Pharmaceuticals Corporation Acquires Santa Fe, New Mexico Plasmapheresis Center
10. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
11. Par Pharmaceutical Announces Outcome of the Litigation With Pentech Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native Douglas James ... Dr. Cottrell has been making predictions about the economy, politics, social issues, as ... these prognostications. He warns that extreme weather conditions and increased earthquake / volcanic ...
(Date:7/29/2015)... Carolina (PRWEB) , ... July 29, 2015 , ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits and ... Challenge North Carolina inclusive sporting event taking place in Charlotte, North Carolina ...
(Date:7/29/2015)... Washington, DC (PRWEB) , ... July 29, 2015 ... ... and aluminum-related illnesses is seeking funding for a study on the potentially lifesaving ... Safety Research Institute today . , The research proposal is based on ...
(Date:7/29/2015)... ... July 29, 2015 , ... One may not expect ... assisted nursing facility, but that’s exactly what was happening on the campus of ... are 3- and 4-year-olds from Kids Only , a five-star childcare center which ...
(Date:7/28/2015)... ... July 29, 2015 , ... Talking About Your Product ... — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline , When a company ... and can’t — say about it is tightly regulated by the FDA. , At ...
Breaking Medicine News(10 mins):Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4
... Marketing Exclusivity Begins -, CORONA, Calif., July ... a leading specialty pharmaceutical,company, announced today that its ... Capsules USP product in the 40mg,strength from its ... Watson has 180 days of marketing exclusivity for ...
... 25 The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Medicine (AAPM) ... IMPAC and CMS are delivering,cutting-edge radiation therapy planning ... create a better experience for,patients, as well as ...
... drop pounds, study finds , , FRIDAY, July 25 (HealthDay ... knows this unalterable truth: Weekends are not a dieter,s ... up dieters, complaints about weekends being their undoing: Most ... they,re trying to lose weight. , "Weekend indulgences can ...
... Administration (FDA) will host the Critical Path Initiative (CPI) on the ... Critical Path Transporter Workshop (October 2-3; North Bethesda, MD). , ... ... [Drug Information Association (DIA)] and the Food and Drug Administration ...
... Canyon Avenue , ... Newport Beach, CA (Vocus) July 24, 2008 -- ... HCP), a Real Estate Investment Trust headquartered in Long Beach, CA, to ... freeway in Irvine, CA. , , , , ,The facility is ...
... Experience it at ... Are you an e-patient?,Studies show that 80 percent of ... Web 2.0, e-patients now have even more ways,to share ... about,advanced medical technologies. Go to http://SutterHealth.org/annualreport ,and you,ll ...
Cached Medicine News:Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 2Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 3Health News:Internet Video Revolution - Sutter Health Harnesses Power of Web 2.0 to Inform Customers 4
(Date:7/28/2015)... , July 28, 2015 The Physician-Patient Alliance ... safety fundraising campaign, " Surviving Your Hospital Stay ." ... care they deserve! None of these patients went home ... and Executive Director, PPAHS) referring to the patient ... National Coalition to Promote Continuous Monitoring of Patients ...
(Date:7/28/2015)... 28, 2015   Vincari , known for their ... just hired John O,Neil as their Executive ... over 30 years of diverse and progressive experience within ... healthcare experience coupled with Vincari,s CMO, Dr. Lucian ... to address the challenges both hospitals and surgeons face, ...
(Date:7/28/2015)... , July 28, 2015 Transparency Market ... titled " Cancer Diagnostics Market - Global Industry ... " . According to this report, the global cancer ... 7.6% during the forecast period of 2014 to 2020. In ... million and is expected to be worth US$168,649.3 million by ...
Breaking Medicine Technology:Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4
... , HAYWARD, Calif. , July 19 Solta ... medical aesthetics market, today announced that it will release its financial ... after market close on Tuesday, August 3, 2010 .  The ... Tuesday, August 3, 2010 , at 4:30 p.m. Eastern Time ...
... PITTSBURGH , July 19 Mastech Holdings, Inc. (NYSE Amex: ... Staffing services, has scheduled a conference call to discuss the results ... will occur on Wednesday, July 28, 2010 , at 9:00 a.m. ... , CEO, and Mr. Jack Cronin , CFO. , ...
Cached Medicine Technology:Solta Medical, Inc. Announces Second Quarter 2010 Results Release Date and Conference Call 2Mastech Holdings, Inc. to Discuss Second Quarter 2010 Financial Results on July 28, 2010 2
... Pulsair EasyEye is the only handheld non-contact ... Pulsair EasyEye is streamlined, quiet and now, ... discomfort, just a gentle puff of air. You ... a demonstration on the patient's hand before you ...
The Emit Phenytoin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of phenytoin in human serum or plasma....
... Phenytoin Assay is a homogeneous ... in the quantitative analysis of ... plasma. Kits are packaged specifically ... COBAS MIRA, COBAS MIRA S, ...
... 1000 assays are designed for ... IMMULITE 1000, continuous random access ... in both design and operation. ... in a wide variety of ...
Medicine Products: